Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Richard Meijer"'
1
Akademický článek
Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer
Autor: Metha Maenhout, Marco van Vulpen, Marinus Moerland, Max Peters, Richard Meijer, Maurice van den Bosch, Paul Nguyen, Steven Frank, Jochem van der Voort van Zyp
Publikováno v: Journal of Contemporary Brachytherapy, Vol 9, Iss 2, Pp 161-166 (2017)
Purpose : Salvage treatments for localized radiorecurrent prostate cancer can be performed safely when a focal and image guided approach is used. Due to the low toxicity, the opportunity exists to investigate a second salvage treatment when a second
Externí odkaz: https://doaj.org/article/670e396b03714c74a6dd2e21a07f16ea
Zobrazit plný text záznamu
2
Urine-derived bladder cancer organoids (urinoids) as tool for cancer longitudinal response monitoring and therapy adaptation
Autor: Bastiaan Viergever, Daniëlle Raats, Veerle Geurts, Jasper Mullenders, Trudy Jonges, Michiel (S.) Van der Heijden, Johan van Es, Onno Kranenburg, Richard Meijer
Bladder cancer is one of the most common cancer-types worldwide. Generally, research relies on invasive sampling strategies. Here, we generate bladder cancer organoids directly from urine (urinoids). In this project, we establish 12 urinoid-lines fro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::23c4e069928b2cede7cd70fb0cf0685d
https://doi.org/10.21203/rs.3.rs-2499089/v1
Zobrazit plný text záznamu
5
Abstract 189: Developing a patient-derived organoid biobank, suitable for large scale drug screenings
Autor: Lars-Eric Fielmich, Annemarie Buijs, Daniele Mori, Bas Viergever, Nihed Draoui, Anna Schepers, Mariana M. Costa e Silva, Mathijs Scholtus, Tokameh Mahmoudi, Tahlita Zuiverloon, Merel Derksen, Paul Gavine, Sylvia F. Boj, Richard Meijer, Onno Kranenburg, Janine Arts, Robert Vries
Publikováno v: Cancer Research. 83:189-189
Conventional models for preclinical drug screening offer poor predictive value for patient response, causing high attrition rates of new agents in the clinic. HUB’s proprietary Patient-Derived Organoid (PDO) Technology enables long-term expansion o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fd5683fc0e56775cb6a8a0358fa38a9b
https://doi.org/10.1158/1538-7445.am2023-189
Zobrazit plný text záznamu
8
Imaging in Drug Development
Autor: Peter Iveson, Andreas Richard Meijer, James Nairne
Imaging has played an important part in the diagnosis of disease and development of the understanding of the underlying disease mechanisms and is now poised to make an impact in the development of new pharmaceuticals. This chapter discusses the under
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c016dcd82a33a85385f3b10a4f5d537c
https://doi.org/10.1016/bs.pmch.2014.10.002
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje